{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:56:03Z","timestamp":1792061763232,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"none"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>HCV infection in hemodialysis units is a significant cause of morbidity and mortality. The risk of HCV infection among dialysis patients is higher compared to the general population due to high potential blood exposures in hemodialysis settings. This study aims to assess the national HCV seroprevalence in selected dialysis units and to determine the risk factors for acquiring HCV infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This cross-sectional study was conducted from 1 January to 31 March 2021. A total of 734 patients from 11 hemodialysis centers in Oman were included. Samples were tested simultaneously for HCV antibodies and HCV RNA. HCV genotyping was determined in all viremic patients. Demographic and hemodialysis\u00a0center related data were gathered and their association with the positive\u00a0HCV serology were explored using univariate and multivariate logistic regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 800 patients selected from 11 dialysis units for the study, 734 patients (91.8%) were included. The overall seroprevalence of HCV infection among hemodialysis patients was 5.6%. (41\/734). HCV RNA was detected in 31.7% (13\/41) of seropositive hemodialysis patients. The most common genotype was subtype 1a, followed by subtype 3. Variables associated with high HCV prevalence were family history of HCV and duration of dialysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The prevalence of infection within hemodialysis patients in Oman has significantly decreased but remained higher than the general population. Continuous monitoring and follow-up, including periodic serosurvey and linkage to care and treatment are recommended. Additionally, practice audits are recommended for identifying gaps and ensuring sustainability of best practices and further improvement.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s44197-023-00149-6","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T14:02:15Z","timestamp":1694527335000},"page":"774-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Seroprevalence of Hepatitis C Virus (HCV) in Hemodialysis Patients in Oman: A National Cross-Sectional Study"],"prefix":"10.1007","volume":"13","author":[{"given":"Intisar","family":"Al Shukri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Al Wahaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Al kindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqoub","family":"Al-Maimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Al Maani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alqayoudhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mersum C.","family":"Methew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jini","family":"Pradeesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiya","family":"Al Abrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdo","family":"Debs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"AlRahbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadha","family":"Al Balushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Alharrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badriya","family":"Al Mamari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda Fakhry","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afraa","family":"Alsenaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al Alawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omaima","family":"Al Ismaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seif","family":"Al-Abri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Al-Jardani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"issue":"3","key":"149_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00705-022-05375-0","volume":"167","author":"RJ Meshram","year":"2022","unstructured":"Meshram RJ, Kathwate GH, Gacche RN. Progress, evolving therapeutic\/diagnostic approaches, and challenges in the management of hepatitis C virus infections. Arch Virol. 2022;167(3):717\u201336. https:\/\/doi.org\/10.1007\/s00705-022-05375-0.","journal-title":"Arch Virol"},{"issue":"4","key":"149_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","volume":"45","author":"JF Perz","year":"2006","unstructured":"Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529\u201338.","journal-title":"J Hepatol"},{"key":"149_CR3","unstructured":"World Health Organization. Hepatitis C key facts. 24 June 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c. Accessed 29 April 2023."},{"issue":"7","key":"149_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/17474124.2020.1776111","volume":"14","author":"MU Khan","year":"2020","unstructured":"Khan MU, Mahmoud MI, Butt AA. Hepatitis C virus and chronic kidney disease. Expert Rev Gastroenterol Hepatol. 2020;14(7):579\u201390. https:\/\/doi.org\/10.1080\/17474124.2020.1776111.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"9","key":"149_CR5","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s40620-022-01483-x","volume":"35","author":"P Greeviroj","year":"2022","unstructured":"Greeviroj P, Lertussavavivat T, Thongsricome T, Takkavatakarn K, Phannajit J, Avihingsanon Y, Praditpornsilpa K, Eiam-Ong S, Susantitaphong P. The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis. J Nephrol. 2022;35(9):2269\u201382. https:\/\/doi.org\/10.1007\/s40620-022-01483-x.","journal-title":"J Nephrol"},{"key":"149_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8109977","author":"NWW Dharmesti","year":"2022","unstructured":"Dharmesti NWW, Wibawa IDN, Kandarini Y. Hepatitis C seroconversion remains high among patients with regular hemodialysis: study of associated risk factors. Int J Hepatol. 2022. https:\/\/doi.org\/10.1155\/2022\/8109977.","journal-title":"Int J Hepatol."},{"issue":"5","key":"149_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/MNH.0000000000000729","volume":"30","author":"A Cohen-Bucay","year":"2021","unstructured":"Cohen-Bucay A, Francis JM, Gordon CE. Progress in hepatitis C virus management in chronic kidney disease. Curr Opin Nephrol Hypertens. 2021;30(5):493\u2013500. https:\/\/doi.org\/10.1097\/MNH.0000000000000729.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"149_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12882-019-1529-1","volume":"20","author":"E Garthwaite","year":"2019","unstructured":"Garthwaite E, Reddy V, Douthwaite S, Lines S, Tyerman K, Eccles J. Clinical practice guideline management of blood borne viruses within the haemodialysis unit. BMC Nephrol. 2019;20(1):388. https:\/\/doi.org\/10.1186\/s12882-019-1529-1.","journal-title":"BMC Nephrol"},{"issue":"3","key":"149_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.kisu.2018.06.001","volume":"8","author":"Kidney Disease Improving Global Outcomes (KDIGO) Hepatitis C Work Group","year":"2018","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO) Hepatitis C Work Group. 2018 KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl (2011). 2018;8(3):91\u2013165. https:\/\/doi.org\/10.1016\/j.kisu.2018.06.001.","journal-title":"Kidney Int Suppl (2011)"},{"key":"149_CR10","unstructured":"Sultanate of Oman ministry of health. Annual health report 2019. 2019. https:\/\/www.moh.gov.om\/en\/web\/statistics\/annual-reports\/-\/asset_publisher\/aQdmeIpTn5pS\/content\/-2-21?inheritRedirect=false&redirect=https%3A%2F%2Fwww.moh.gov.om%2Fen%2Fweb%2Fstatistics%2Fannual-reports%3Fp_p_id%3D101_INSTANCE_aQdmeIpTn5pS%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26p_p_col_id%3Dcolumn-2%26p_p_col_count%3D1. Accessed 7 July 2023."},{"issue":"4","key":"149_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.kint.2018.11.038","volume":"95","author":"M Jadoul","year":"2019","unstructured":"Jadoul M, Bieber BA, Martin P, Akiba T, Nwankwo C, Arduino JM, Goodkin DA, Pisoni RL. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int. 2019;95(4):939\u201347.","journal-title":"Kidney Int"},{"issue":"1","key":"149_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3748\/wjg.v23.i1.151","volume":"23","author":"S Ashkani-Esfahani","year":"2017","unstructured":"Ashkani-Esfahani S, Alavian SM, Salehi-Marzijarani M. Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: a systematic review and meta-analysis. World J Gastroenterol. 2017;23(1):151.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"149_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/BF01710538","volume":"21","author":"SHS Al-Dhahry","year":"1993","unstructured":"Al-Dhahry SHS, Buhl MR, Daar AS, Aganashinikar PN, Al-Hasani MK. Prevalence of antibodies to hepatitis C virus among Omani patients with renal disease. Infection. 1993;21(3):164\u20137.","journal-title":"Infection"},{"issue":"4","key":"149_CR14","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4103\/1319-2442.292317","volume":"31","author":"A AlSahow","year":"2020","unstructured":"AlSahow A, AlHelal B, Alyousef A, AlQallaf A, Marzouq A, Nawar H, Fanous G, Abdelaty M, Bahbahani Y, AlRajab H, AlTerkait A, Ali H. Renal data from the Arab world dialysis in Kuwait: 2013\u201319. Saudi J Kidney Dis Transpl. 2020;31(4):826\u201330. https:\/\/doi.org\/10.4103\/1319-2442.292317.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"149_CR15","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.4103\/1319-2442.352433","volume":"32","author":"M Hajji","year":"2021","unstructured":"Hajji M, Barbouch S, Manaa R, Ajimi K, Hamida FBB, Goucha R, Gorsane I, Abdallah TB. National epidemiological study about hepatitis C virus infection among dialysis patients. Saudi J Kidney Dis Transpl. 2021;32(6):1715\u201321. https:\/\/doi.org\/10.4103\/1319-2442.352433.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"5","key":"149_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232931","volume":"15","author":"S Akhtar","year":"2020","unstructured":"Akhtar S, Nasir JA, Usman M, Sarwar A, Majeed R, Billah B. The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: a systematic review and meta-analysis. PLoS ONE. 2020;15(5): e0232931. https:\/\/doi.org\/10.1371\/journal.pone.0232931.","journal-title":"PLoS ONE"},{"issue":"1","key":"149_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1186\/s12879-022-07833-1","volume":"22","author":"T Zitha","year":"2022","unstructured":"Zitha T, Chen CY, Mudawi H, Hussein W, Mukhtar M, Shigidi M, Yousif MEA, Ali MA, Glebe D, Kramvis A. Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis. BMC Infect Dis. 2022;22(1):848. https:\/\/doi.org\/10.1186\/s12879-022-07833-1.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"149_CR18","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.18295\/squmj.2017.17.04.005","volume":"17","author":"SA Al-Busafi","year":"2017","unstructured":"Al-Busafi SA, Al-Shuaili H, Omar H, Al-Zuhaibi H, Jeyaseelan L, Al-Naamani K. Epidemiology of chronic hepatitis c infections at a tertiary care centre in Oman. Sultan Qaboos Univ Med J. 2017;17(4):e404\u201310. https:\/\/doi.org\/10.18295\/squmj.2017.17.04.005.","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"6","key":"149_CR19","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","volume":"65","author":"RB Fissell","year":"2004","unstructured":"Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004;65(6):2335\u201342.","journal-title":"Kidney Int"},{"issue":"1","key":"149_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41598-021-03961-x","volume":"12","author":"RP Niquini","year":"2022","unstructured":"Niquini RP, da Corr\u00eaa MJ, Bastos LS, da Costa Moreira Barbosa D, Falc\u00e3o JDS, Palmieri P, Martins P, Melo Villar L, Bastos FI. Persistently high hepatitis C rates in haemodialysis patients in Brazil [a systematic review and meta-analysis]. Sci Rep. 2022;12(1):330. https:\/\/doi.org\/10.1038\/s41598-021-03961-x.","journal-title":"Sci Rep"},{"issue":"15","key":"149_CR21","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1017\/S0950268817002242","volume":"145","author":"M Harfouche","year":"2017","unstructured":"Harfouche M, Chemaitelly H, Mahmud S, Chaabna K, Kouyoumjian SP, Al Kanaani Z, Abu-Raddad LJ. Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions. Epidemiol Infect. 2017;145(15):3243\u201363. https:\/\/doi.org\/10.1017\/S0950268817002242.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"149_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/sdi.12761","volume":"32","author":"DB Nguyen","year":"2019","unstructured":"Nguyen DB, Bixler D, Patel PR. Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention. Semin Dial. 2019;32(2):127\u201334. https:\/\/doi.org\/10.1111\/sdi.12761.","journal-title":"Semin Dial"},{"issue":"5","key":"149_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S2468-1253(21)00471-4","volume":"7","author":"EB Cunningham","year":"2022","unstructured":"Cunningham EB, Wheeler A, Hajarizadeh B, French CE, Roche R, Marshall AD, Fontaine G, Conway A, Valencia BM, Bajis S, Presseau J, Ward JW, Degenhardt L, Dore GJ, Hickman M, Vickerman P, Grebely J. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(5):426\u201345. https:\/\/doi.org\/10.1016\/S2468-1253(21)00471-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"149_CR24","unstructured":"Sultanate of Oman ministry of health. Policy and procedure of blood donor counselling (Pre-donation) .https:\/\/moh.gov.om\/documents\/17733\/7264498\/Donor+counselling%28pre-donation%29.pdf\/8035b0c6-4f85-8bed-8da6-999fa56ba559.Acseesed August 2023."}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-023-00149-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-023-00149-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-023-00149-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T07:24:17Z","timestamp":1701242657000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-023-00149-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1007\/s44197-023-00149-6","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Centre of Studies & Research of the Ministry of Health-(IRA number MoH\/CSR\/19\/ 0940). Written informed consent was obtained from all individuals prior to study participation and blood collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"NA.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}